James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

2 More Reasons to Believe in the IBM Stock Turnaround

If you thought IBM stock was still unownable, think again. Here are two more reasons IBM is restoring its relevancy.

Surprise! Rite Aid Corporation Looks Ready For Decent Gain

Rite Aid Corporation still has a whole host of problems to solve, but RAD stock is acting like it wants to undo some of the pointless damage it suffered in 2017.

2018 Should Be Better for Celgene Corporation and CELG Stock

CELG stock suffered in 2017 after some disappointing news, but Celgene has set the stage for a much better 2018. Here’s what to look for.

3 Reasons Macy’s Inc Stock May Finally Be Worth a Shot

Macy's stock has been the scourge of the retail world since early 2016, but a closer look reveals Macy's Inc may finally see a light at the end of the tunnel.

3 Things to Watch with Intel Corporation Stock in 2018

If you own, or might buy, INTC stock soon, here are the big things that are going to make or break Intel in the coming year.